A detailed history of Royal Bank Of Canada transactions in Siga Technologies Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 4,618 shares of SIGA stock, worth $26,461. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,618
Previous 6,357 27.36%
Holding current value
$26,461
Previous $48,000 35.42%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.74 - $11.97 $11,720 - $20,815
-1,739 Reduced 27.36%
4,618 $31,000
Q2 2024

Aug 14, 2024

BUY
$6.32 - $10.46 $7,874 - $13,033
1,246 Added 24.38%
6,357 $48,000
Q1 2024

Nov 05, 2024

SELL
$4.51 - $8.92 $5,619 - $11,114
-1,246 Reduced 19.6%
5,111 $43,000
Q1 2024

May 15, 2024

SELL
$4.51 - $8.92 $38,186 - $75,525
-8,467 Reduced 62.36%
5,111 $43,000
Q4 2023

Feb 14, 2024

BUY
$4.82 - $6.25 $27,994 - $36,300
5,808 Added 74.75%
13,578 $76,000
Q3 2023

Nov 14, 2023

BUY
$4.32 - $5.77 $12,571 - $16,790
2,910 Added 59.88%
7,770 $40,000
Q2 2023

Aug 14, 2023

BUY
$5.0 - $6.31 $625 - $788
125 Added 2.64%
4,860 $24,000
Q1 2023

May 15, 2023

SELL
$5.23 - $8.42 $24,832 - $39,978
-4,748 Reduced 50.07%
4,735 $27,000
Q4 2022

Feb 14, 2023

SELL
$7.29 - $10.14 $9,389 - $13,060
-1,288 Reduced 11.96%
9,483 $69,000
Q3 2022

Nov 14, 2022

BUY
$10.02 - $26.15 $83,316 - $217,437
8,315 Added 338.56%
10,771 $111,000
Q2 2022

Aug 15, 2022

SELL
$6.5 - $13.68 $16,308 - $34,323
-2,509 Reduced 50.53%
2,456 $28,000
Q1 2022

May 16, 2022

SELL
$5.96 - $7.61 $58,527 - $74,730
-9,820 Reduced 66.42%
4,965 $35,000
Q4 2021

Feb 14, 2022

BUY
$6.96 - $9.26 $50,592 - $67,310
7,269 Added 96.71%
14,785 $111,000
Q3 2021

Nov 15, 2021

BUY
$5.71 - $7.39 $12,139 - $15,711
2,126 Added 39.44%
7,516 $56,000
Q2 2021

Aug 16, 2021

BUY
$6.1 - $7.58 $32,879 - $40,856
5,390 New
5,390 $34,000

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $418M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.